Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
about
Severity and management of psoriasis within primary care.Sustained PASI, DLQI and EQ-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.PASI90 response: the new standard in therapeutic efficacy for psoriasis.Use of biologics for psoriasis in Central and Eastern European countries.How is disease severity associated with quality of life in psoriasis patients? Evidence from a longitudinal population-based study in Sweden.EQ-5D in Central and Eastern Europe: 2000-2015.Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity.Biologicals and small molecules in psoriasis: A systematic review of economic evaluations.A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study.Treatment satisfaction, willingness to pay and quality of life in Japanese patients with psoriasis.Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres.Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.
P2860
Q36163078-4C45DDE0-32DB-4D33-880D-72446937F973Q36413344-385BD1FA-2A44-4504-86E0-7616C357ED19Q38265085-AA1AABEC-066D-44B5-9681-824E9F5A2857Q38586836-F80A11C9-5497-4AD4-8B05-2187649F0254Q38654766-0F9EC68F-0C8E-4535-ACFC-88AF559EC7D4Q38912637-D15114CD-B13D-4A87-B855-B1E551C0BD34Q39078782-46752604-D22E-4BC9-9A36-9F81DC5EF4FFQ47292115-48A6B05C-A919-4698-9859-251475DF69DAQ47586627-D4C14A5A-B12B-4843-BFA4-436D0EEADE12Q47674064-0355E7A0-00BD-4C3E-81E4-3891C4E9B5E5Q47694111-6C476DC3-4764-456E-AFDA-5106EA0B2137Q48076350-D1378B89-85EF-448C-9B34-4FC34576831AQ48123615-3F45FC08-D109-4BB2-A000-500EA0BA24D3Q48368354-026F6861-BE11-463F-BE7B-A6B9E0E609F4
P2860
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Exploring the relationship bet ...... udy in psoriasis from Hungary.
@en
Exploring the relationship bet ...... udy in psoriasis from Hungary.
@nl
type
label
Exploring the relationship bet ...... udy in psoriasis from Hungary.
@en
Exploring the relationship bet ...... udy in psoriasis from Hungary.
@nl
prefLabel
Exploring the relationship bet ...... udy in psoriasis from Hungary.
@en
Exploring the relationship bet ...... udy in psoriasis from Hungary.
@nl
P2093
P2860
P1476
Exploring the relationship bet ...... tudy in psoriasis from Hungary
@en
P2093
Andrea Szegedi
Emese Herédi
Fanni Rencz
Hajnalka Jókai
Krisztina Herszényi
László Gulácsi
Márta Péntek
Orsolya Balogh
Péter Holló
Valentin Brodszky
P2860
P2888
P304
P356
10.1007/S10198-014-0600-X
P478
15 Suppl 1
P577
2014-05-16T00:00:00Z